Elon Musk receives authorization for putting a computer chip in people’s brains: Know more about Neuralink
With approval from the US Food and Drug Administration (FDA) to begin its first-in-human clinical research, Neuralink, the brain implant business founded by Elon Musk, has accomplished a key milestone. With past difficulties securing regulatory permission, this approval represents a significant turning point for Neuralink. The human trials of Neuralink’s brain implant, which has the ability to treat serious illnesses including paralysis and blindness, have been anticipated by Musk since 2019. Nevertheless, despite the company’s founding in 2016, the FDA clearance procedure wasn’t started by Neuralink until early 2022. Sadly, the agency turned down their application, according to information provided…